Medicaid ends funding for child sex-change procedures as Trump admin slams 'experimental' treatments
Left (0)
No coverage found from this side yet.
Center (0)
No coverage found from this side yet.
Right (5)
Trump Admin Ends Medicaid, CHIP Funding For ‘Trans’ Child Mutilation Procedures
'Children deserve our protection, not experimental interventions that pose serious risks and convey no proven benefits,' said CMS Administrator Mehmet Oz.
Aug 12, 2026
Medicaid to stop funding child sex-change hormones and surgeries, Trump admin vows to protect kids from ‘experimental’ procedures
Taxpayers will no longer be on the hook for child sex-change hormones or surgeries, as a Trump administration agency announced Tuesday that Medicaid will stop funding such procedures and therapies.
Aug 11, 2026
Trump Admin Ends Medicaid Funding For Child ‘Sex-Rejecting’ Procedures
The Trump administration announced Tuesday that a final rule barring federal Medicaid and Children’s Health Insurance Program (CHIP) funds from being used to pay for transgender medical interventions for minors, including puberty blockers, cross-sex hormones, and surgeries. “Today, we are ending federal taxpayer funding for sex-rejecting procedures on children,” Health and Human Services Secretary Robert F. ...
Aug 11, 2026
Trump administration finalizes end to Medicaid funding for child sex change procedures
The Trump administration is finalizing rules to end Medicaid funding for sex change procedures, including cross-sex surgeries and hormones, for minors. The Department of Health and Human Services is finalizing a controversial rule that would block Medicaid reimbursement for healthcare providers who give gender transition procedures to minors, the Washington Examiner confirmed. HHS spokeswoman Emily […]
Aug 11, 2026
Medicaid ends funding for child sex-change procedures as Trump admin slams 'experimental' treatments
CMS under Mehmet Oz announces Medicaid and CHIP will no longer fund puberty blockers, cross-sex hormones, or sex change surgeries for children.
Aug 11, 2026